Human immunodeficiency virus-positive individuals with oral hairy leukoplakia are able to mount cytotoxic T lymphocyte responses to Epstein- Barr virus

Oral Diseases

Volumn 6, Issue 1, 2000, Pages 40-47

  de Jong, A ^a,b   Palefsky, J M ^a   Stites, D P ^a   Nakagawa, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Cytotoxic T lymphocyte; Epstein Barr virus; Oral hairy leukoplakia

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPLAKIA; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; HERPESVIRUS 4, HUMAN; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; KILLER CELLS, NATURAL; LEUKOPLAKIA, HAIRY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033966118     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2000.tb00320.x     Document Type: Article

References (43)

1. Andersson ML, Stam NJ, Klein G et al (1991). Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells. Int J Cancer 47: 544-550.
2. Aragues M, Sanchez Perez J, Fraga J et al (1990). Hairy leucoplakia - a clinical, histopathological and ultrastructural study in 33 patients. Clin Exp Dermatol 15: 335-339.
3. Blumberg RS, Paradis T, Byington R et al (1987). Effects of human immunodeficiency virus on the cellular immune response to Epstein-Barr virus in homosexual men: characterization of the cytotoxic response and lymphokine production. J Infect Dis 155: 877-890.
4. Callan MF, Tan L, Annels N et al (1998). Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp Med 187: 1395-1402.
5. Carmichael A, Jin X, Sisssons P et al (1993). Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 177: 249-256.
6. Feigal DW, Mithcell HK, Greenspan D et al (1991). The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 5: 519-525.
7. Geretti AM, Dings ME, van Els CA et al (1996). Human immunodeficiency virus type 1 (HIV-1) - and Epstein-Barr virus - specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1 infected persons. J Infect Dis 174: 34-45.
8. Glick M, Muzyka BC, Lurie D et al (1994). Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 77: 344-349.
9. Greenspan D, Greenspan JS (1996). HIV-related oral disease. Lancet 348: 729-733.
10. Greenspan D, Greenspan JS, Conant M et al (1984). Oral 'hairy' leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet 2: 831-834.
11. Greenspan JS, Greenspan D, Palefsky JM (1995). Oral hairy leucoplakia after a decade. Epstein-Barr Virus Report 2: 123-128.
12. Gregory CD, Murray RJ, Edwards CF et al (1988). Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 167: 1811-1824.
13. Henle G, Henle W (1979). The virus as the etiologic agent of infectious mononucleosis. In: Epstein M, Anchong B, eds. The Epstein-Barr virus. Springer-Verlag: Berlin, pp 297-320.
14. Hill AB, Lee SP, Haurum JS et al (1995). Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. J Exp Med 181: 2221-2228.
15. Husak R, Garbe C, Orfanos CE (1996). Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol 35: 928-934.
16. Itin PH (1993). Oral hairy leukoplaia - 10 years on. Dermatology 187: 159-163.
17. Kersten MJ, Klein MR, Holwerda AM et al (1997). Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. J Clin Invest 99: 1525-1533.
18. Khanna R, Burrows SR, Argaet V et al (1994). Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumor cell line. Int Immunol 6: 639-645.
19. Khanna R, Burrows SR, Steigerwald-Mullen PM et al (1995). Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. Virology 214: 633-637.
20. Khanna R, Burrows SR, Thomson SA et al (1997). Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs. J Immunol 158: 3619-3625.
21. Kieff E (1996). Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, eds. Field's virology. Lippencott-Raven: Philadelphia, pp 2343-2396.
22. King GN, Healy CM, Glover MT et al (1994). Prevalence and risk factors associated with leukoplakia, hairy leukoplaia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol 78: 718-726.
23. Klein G (1994). Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77: 791-793.
24. Konttinen YT, Bluestein HG, Zvaifler NJ (1985). Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells. J Immunol 134: 2287-2293.
25. Konttinen YT, Bluestein HG, Zvaifler NJ (1986). Regulation of the growth of Epstein-Barr virus-infected B cells: temporal profile of the in vitro development of three distinct cytotoxic cells. Cell Immunol 103: 84-95.
26. Lifson AR, Hilton JF, Westenhouse JL et al (1994). Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 8: 73-79.
27. Mabruk MJ, Flint SR, Toner M et al (1994). In situ hybridization and the polymerase chain reaction (PCR) in the analysis of biopsies and exfoliative cytology specimens for definitive diagnosis of oral hairy leukoplakia (OHL). J Oral Pathol Med 23: 302-308.
28. Masucci MG (1990). Cell phenotype dependent down-regulation of MHC class I antigens in Burkitt's lymphoma cells. Curr Top Microbiol Immunol 166: 309-316.
29. Meuer SC, Cooper DA, Hodgdon JC et al (1983). Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations. J Immunol 131: 1167-1172.
30. Misko IS, Moss DJ, Pope JH (1980). HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc Natl Acad Sci USA 77: 4247-4250.
31. Misko IS, Pope JH, Hutter R et al (1984). HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies. Int J Cancer 33: 239-243.
32. Palefsky JM, Berline J, Penaranda ME et al (1996). Sequence variation of latent membrane protein-1 of Epstein-Barr virus strains associated with hairy leukoplakia. J Infect Dis 173: 710-714.
33. Penaranda ME, Lagenaur LA, Pierik LT et al (1997). Expression of Epstein-Barr virus BMRF-2 and BDLF-3 genes in hairy leukoplaia. J Gen Virol 78: 3361-3370.
34. Rabanus JP, Greenspan D, Petersen V et al (1991). Subcellular distribution and life cycle of Epstein-Barr virus in keratinocytes of oral hairy leukoplakia. Am J Pathol 139: 185-197.
35. Rickinson AB, Kieff E (1996). The Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Field's virology. Lippencott-Raven: Philadelphia, pp 2397-2446.
36. Shi Y, Smith KD, Kurilla MG et al (1997) Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. J Immunol 159: 1844-1852.
37. Sixbey JW, Pagano JS (1984). New perspectives on the Epstein-Barr virus in the pathogenesis of lymphoproliferative disorders. In: Swartz MN, Remmington JS, eds. Current clinical topics in infectious diseases. McGraw-Hill: New York, pp 146-176.
38. Steven NM, Annels NE, Kumar A et al (1997). Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med 185: 1605-1617.
39. Wallace LE, Murray RJ, Lee SP et al (1993). Cell-mediated immunity to Epstein-Barr virus. In: Thomas DB, ed. Viruses and the cellular immune response. Marcel Dekker Inc: New York, pp 447-472.
40. Wallace LE, Rickinson AB, Rowe M et al (1982a). Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature 297: 413-415.
41. Wallace LE, Rickinson AB, Rowe M et al (1982b). Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response. Cell Immunol 67: 129-140.
42. Walling DM, Raab-Traub N (1994). Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J Virol 68: 7909-7917.
43. Young LS, Lau R, Rowe M et al (1991). Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 65: 2868-2874.